Related Experiment Video

Updated: Aug 9, 2026

Cranial Neural Crest Cells Three-Dimensional In Vitro Differentiation Protocol for Multiplexed Assay
08:55

Cranial Neural Crest Cells Three-Dimensional In Vitro Differentiation Protocol for Multiplexed Assay

Published on: February 14, 2025

NOV/CCN3 impairs muscle cell commitment and differentiation

Frederico Calhabeu1, Jérome Lafont, Gwenvael Le Dreau

  • 1Unité INSERM 515, Hôpital Saint-Antoine, 184 rue du Faubourg Saint-Antoine, 75371 Paris, France; Pierre and Marie Curie University, Paris.

Experimental Cell Research
|April 8, 2006
PubMed

Insights

Nephroblastoma overexpressed (NOV) protein inhibits muscle cell differentiation by downregulating key myogenic genes like MyoD. This suggests NOV acts as a cell fate regulator, controlling the transition from progenitor cells to myoblasts.

Area of Science:

  • Cell biology
  • Developmental biology
  • Molecular biology

Background:

  • Nephroblastoma overexpressed (NOV) is a secreted matrix-associated protein.
  • NOV expression occurs during embryonic development in dermomyotome and limb buds.
  • The precise functions of NOV, particularly in muscle development, remain largely undefined.

Purpose of the Study:

  • To investigate the role of NOV in myogenic differentiation.
  • To elucidate the molecular mechanisms by which NOV influences muscle cell fate.

Main Methods:

  • Overexpression of NOV in C2C12 muscle progenitor cells (C2-NOV).
  • Assessment of myogenic and osteogenic differentiation potential of C2-NOV cells.
  • Analysis of key myogenic regulatory gene expression (MyoD, Myf5) and IGF-II.
  • Forced expression of MyoD in C2-NOV cells to assess rescue effects.
  • Investigation of HES1 involvement.

Main Results:

  • C2-NOV cells failed to undergo myogenic differentiation but retained osteogenic potential.
  • NOV overexpression prevented myotube formation and expression of differentiation markers in C2C12 and primary human muscle cells.
  • NOV significantly downregulated MyoD, Myf5, and IGF-II expression.
  • Forced MyoD expression rescued differentiation and IGF-II induction in C2-NOV cells.
  • NOV acts upstream of MyoD and does not impact IGF-II signaling; HES1 is not involved.

Conclusions:

  • NOV acts as a specific cell fate regulator within the myogenic lineage.
  • NOV negatively regulates critical myogenic genes, thereby controlling the transition of progenitor cells to myoblasts.
  • NOV's inhibitory effect on differentiation is mediated through MyoD downregulation.

More Related Videos

Culturing and Manipulation of O9-1 Neural Crest Cells08:32

Culturing and Manipulation of O9-1 Neural Crest Cells

Published on: October 9, 2018

Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes10:48

Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes

Published on: April 12, 2015

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Stem Cell Niche01:26

Stem Cell Niche

The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.